RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
11 Articles in this Series
Introduction
A PAINWeek 2019 preview with EVP Debra Weiner
Comparing Marijuana and Hemp
Fibromyalgia: What’s New in Diagnosis and Pain Management
Life Hacks to Teach Patients with Chronic Pain
Managing Pain (and Function) in Osteoarthritis: Are Patients and Physicians on the Same Page?
Marijuana: How to Proceed When Controlled Substances are Involved
Menopause Comes with More than Mood Swings - It Deserves its Place Among Chronic Pain Conditions
More APPs Are Coming to the Forefront of Pain Care
Motivational Interviewing and Its Extension into Pain Management
Revisiting Documentation
Side Chat: Modern Analgesic Trials

A PAINWeek 2019 preview with EVP Debra Weiner

A PAINWeek 2019 preview with Debra Weiner, PAINWeek’s Executive Vice President for Program Development

The conversation in pain management continues to lean toward opioid alternatives for managing chronic pain conditions long-term. How will PAINWeek 2019 address this focus?

As always, we will present 120-plus hours of CE/CME over the 5-day conference. While opioids still remain an important analgesic, alternatives to medication management in general will be presented. Among them will be:

  • Dorsal Root Ganglion: Neuromodulation as an Alternative to Opioids
  • Injections, Nerve Blocks, Pumps, and Spinal Cord Stimulation
  • Spinal Stenosis: Epidemiology, Pathophysiology, and Treatment
  • Stem Cells and Regenerative Medicine for Non-resolving Inflammation
  • Neuromodulation for Advanced Practice Providers
  • Geriatric Pain Management: Minimally Invasive Interventions
  • An Integrative Pain Management Program: What Does a Multi-Modal Program for Chronic Pain Look Like?

 

What special sessions will be available that have not been offered in past years? For instance, one of the new workshops focuses on ultrasonography – why was this topic chosen?

We had never presented an ultrasonography workshop before, and our faculty thought this would be a timely topic. Emerging applications continue to evolve with new developments in peripheral nerve stimulation and regenerative medicine, cryotherapy, and radiofrequency will be covered. We also have a workshop called “Hitting The Bull’s Eye In Pain Management: Using All The Arrows In Your Quiver,” which will address appropriate use of different medications in lieu of – or in combination with – opioid therapy. The third and final workshop is “Rotate the Molecule! Rationalizing Excessive Opioid Prescribing with Buprenorphine” where cases will provide learners with a better understanding of initiation, stabilization, maintenance, and exit strategies.

 

What tracks are woven into this year’s sessions that attendees may find useful and timely?

Given the interest in cannabinoids, we are presenting a Special Interest Session, “The World According to Cannabinoids” along with a full-day track on Friday, September 6. Returning for their third year is the International Pelvic Pain Society, and they will present a full-day agenda on pelvic-related pain. This year, we also welcome the International Myopain Society who will cover “Transformative Care for Myopain: Enhancing Long-Term Success in Myofascial Pain and Fibromyalgia.” The American Headache Society will present their “Chronic Migraine Education Program.”

As always, our Medical/Legal track is tailored to the most timely and relevant practitioner needs with “Inside the Trojan Horse: Addressing Current Legal Actions Against Healthcare Practitioners” and “Embrace Changes and Prevent Overdose: A Basic Blueprint for Legal Risk Mitigation and Response.”

 

PAINWeek is known for its annual location (Las Vegas) and for its artistic approach to promoting session titles and authors. Can we give a shout-out to the creator of the posters lining the conference hallways each year?

Sure, our Art Director, Darryl Fossà produces all of the original artwork, graphic design, and branding that we use for PAINWeek. See a sample above. •

 

-Q&A by PPM Editor Angie Drakulich

 

Next summary: Comparing Marijuana and Hemp
close X
SHOW MAIN MENU
SHOW SUB MENU